Revised SPC: Tafinlar (dabrafenib mesilate) hard capsules – all strengths

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
10 April 2019

Abstract

Sections 4.4 and 4.8 have been updated to include information about possible adverse events when used in combination with trametinib based on data from the BRF117277 study evaluating the combination in patients with brain metastases.